12:00 AM
Sep 28, 2015
 |  BioCentury  |  Finance

Loose lips

Looking at value lost over three decades of the Clintons talking biotech

When it comes to Clinton proclamations that destroy value in the biotech sector, Hillary holds the market cap title but Bill still has the record in terms of one-week percent declines.

Last Monday, Hillary Clinton's announcement that she would address "price gouging" on specialty drugs sent the biotech sector into a tailspin. At week's end, the BioCentury 100 index was off 14%. All told, $145 billion of aggregate market cap evaporated from the sector last week, or 10% of the industry's total valuation.

That's the equivalent of Gilead...

Read the full 431 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >